Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
15.74
-0.05 (-0.32%)
At close: Feb 21, 2025, 4:00 PM
15.89
+0.15 (0.95%)
After-hours: Feb 21, 2025, 5:11 PM EST
Xencor Employees
Xencor had 280 employees as of December 31, 2023. The number of employees decreased by 1 or -0.36% compared to the previous year.
Employees
280
Change (1Y)
-1
Growth (1Y)
-0.36%
Revenue / Employee
$304,157
Profits / Employee
-$708,000
Market Cap
1.10B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
XNCR News
- 4 days ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 3 months ago - Xencor to Participate at Upcoming Investor Conferences - Business Wire
- 3 months ago - Xencor: Plamotamab NHL Data Leads To RA Program Advancement - Seeking Alpha
- 3 months ago - Xencor Reports Third Quarter 2024 Financial Results - Business Wire
- 3 months ago - Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - Business Wire
- 4 months ago - Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases - Business Wire
- 5 months ago - Xencor Announces Upcoming Change to Board of Directors - Business Wire
- 5 months ago - Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire